Clinical Trials Logo

Clinical Trial Details — Status: No longer available

Administrative data

NCT number NCT02312037
Other study ID # B1761026
Secondary ID
Status No longer available
Phase
First received
Last updated

Study information

Verified date August 2019
Source Pfizer
Contact n/a
Is FDA regulated No
Health authority
Study type Expanded Access

Clinical Trial Summary

An expanded access/compassionate use protocol that allows access to Mylotarg for relapsed/refractory AML CD33 positive patients in the USA.

Contact: B1761026@iconplc.com


Description:

Contact:

B1761026@iconplc.com


Recruitment information / eligibility

Status No longer available
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender All
Age group 3 Months and older
Eligibility Inclusion Criteria:

- Confirmed diagnosis of relapsed/refractory AML (defined as >=5% marrow blasts by morphology), including MDS, with persisting rising blasts and no other comparable or satisfactory alternative therapy available. If bone marrow has <5% blasts by morphology but the patient has evidence of relapse with extra-medullary disease progression. In select cases presenting with conversion of MRD from negative to positive, treatment with GO may be allowed where no alternative treatments are feasible.

OR

- Confirmed diagnosis of relapsed or refractory APL with persisting or rising leukemic burden (either by morphology, cytogenetic analysis or by molecular techniques), and no other comparable or satisfactory alternative therapy available.

- Documentation that malignant cells express CD33

4) Age >=3 months

5) Adequate non-hematologic organ function

Exclusion Criteria:

- Untreated AML and MDS or AML and MDS in complete remission.

- Patients with a known history of VOD/SOS.

- Patients with a known hypersensitivity to Mylotarg or its parts: hP67.6 antibody, calicheamicin derivatives or other ingredients.

- Participation in other studies involving investigational drug(s) (Phases 1-4) during study participation.

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Antibody Drug Conjugate Chemotherapeutic
Three Treatment Regimens: Mylotarg <=9 mg/m2 as a single agent on Day 1 & 14 of a 28-day cycle for a total of two cycles Mylotarg in combination with a recognized anthracycline and/or nucleoside-antagonist containing regimen Mylotarg as monotherapy or in tested combinations with ATRA and/or arsenic trioxide for APL

Locations

Country Name City State
United States Alaska Oncology & Hematology, LLC Anchorage Alaska
United States Providence Alaska Medical Center Anchorage Alaska
United States Providence Cancer Center Anchorage Alaska
United States Fox Valley Hematology & Oncology, SC Appleton Wisconsin
United States Children's Healthcare of Atlanta at Egleston Atlanta Georgia
United States Children's Healthcare of Atlanta at Scottish Rite Atlanta Georgia
United States Northside Hospital Atlanta Georgia
United States The Blood & Marrow Transplant Group Of Georgia Atlanta Georgia
United States Children's Blood and Cancer Center Austin Texas
United States Dell Children's Medical Center Austin Texas
United States Dell Children's Medical Center of Central Texas Austin Texas
United States Johns Hopkins University Baltimore Maryland
United States Johns Hopkins University IDS Pharmacy Baltimore Maryland
United States University of Alabama at Birmingham/Children's of Alabama Birmingham Alabama
United States Massachusetts General Hospital Boston Massachusetts
United States Roswell Park Cancer Institute Buffalo New York
United States Cancer Center IDS Pharmacy Attn: Lauren Benusa, Pharm D. Charlottesville Virginia
United States Emily Couric Clinical Cancer Center Charlottesville Virginia
United States UVA Health System Charlottesville Virginia
United States Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois
United States Investigational Drugs Service Pharmacy, Attn. Judy Pi, PharmD, Ami Patel, PharmD Chicago Illinois
United States The University of Chicago Chicago Illinois
United States The University of Chicago Medical Center Chicago Illinois
United States University of Chicago Medical Center Chicago Illinois
United States University Hospitals of Cleveland Rainbow Babies & Children's Hospital Cleveland Ohio
United States Nationwide Children's Hospital Columbus Ohio
United States Siteman Cancer Center - West County Creve Coeur Missouri
United States Geisinger Medical Center Danville Pennsylvania
United States North Shore Hematology Oncology Associates, P.C. East Setauket New York
United States El Paso Children's Hospital El Paso Texas
United States Texas Tech University Health Sciences Center El Paso Texas
United States Cook Children's Hematology/Oncology Center Fort Worth Texas
United States Cook Children's Medical Center Fort Worth Texas
United States The West Clinic, P.C. dba West Cancer Center Germantown Tennessee
United States Cook Children's Hematology/Oncology Center - Grapevine Grapevine Texas
United States Aurora BayCare Medical Center Green Bay Wisconsin
United States Brody School of Medicine at ECU Greenville North Carolina
United States Vidant Medical Center Greenville North Carolina
United States Virginia Oncology Associates Hampton Virginia
United States Milton Hershey Medical Center Hershey Pennsylvania
United States JDCH pediatric Oncology and Hematology Hollywood Florida
United States Joe Dimaggio Children's Hospital Hollywood Florida
United States Memorial Regional Hospital Hollywood Florida
United States Houston Methodist Cancer Center Houston Texas
United States Houston Methodist Hospital Houston Texas
United States Texas Children's Hospital Houston Texas
United States Texas Children's Hospital Attn: Investigational Pharmacy Services Houston Texas
United States Indiana Blood and Marrow Transplantation Indianapolis Indiana
United States Indiana Blood and Marrow Transplantation - Administrative Offices Indianapolis Indiana
United States Indiana University Riley Hospital for Children Indianapolis Indiana
United States IU Health Pharmacy Indianapolis Indiana
United States St.Francis Hospital Indianapolis Indiana
United States Baptist Medical Center/Wolfson Children's Hospital Jacksonville Florida
United States Nemours Children's Clinic Jacksonville Florida
United States Children's Mercy Hospital Kansas City Missouri
United States University of Kansas Hospital Kansas City Kansas
United States East Tennessee Children's Hospital Knoxville Tennessee
United States UK Healthcare Markey Cancer Center Lexington Kentucky
United States Children's Hospital Of Los Angeles - University Of Southern California School Of Medicine Los Angeles California
United States Cardinal Bernardin Cancer Center/Loyola University Medical Center Maywood Illinois
United States Loyola University Chicago, performing research at Loyola University Medical Center Maywood Illinois
United States Loyola University Medical Center Maywood Illinois
United States Baptist Memorial Hospital Memphis Tennessee
United States St. Jude Children's Research Hospital Memphis Tennessee
United States The West Clinic, P.C. dba West Cancer Center Memphis Tennessee
United States Banner Pediatric Specialists Hematology/Oncology Clinic Mesa Arizona
United States Cardon Children's Medical Center. Mesa Arizona
United States Children's Hospital of Wisconsin Milwaukee Wisconsin
United States Medical College of Wisconsin Milwaukee Wisconsin
United States Monroe Carell Jr. Children's Hospital at Vanderbilt Nashville Tennessee
United States Sarah Cannon Center for Blood Cancer Nashville Tennessee
United States Sarah Cannon Research Institute Nashville Tennessee
United States Sarah Cannon Research Institute Nashville Tennessee
United States Tennessee Oncology - Nashville Nashville Tennessee
United States Tennessee Oncology, PLLC Nashville Tennessee
United States The Children's Hospital at TriStar Centennial Nashville Tennessee
United States TriStar Centennial Medical Center Nashville Tennessee
United States TriStar Centennial Medical Center/Sarah Cannon Cener for Blood Cancer Nashville Tennessee
United States TriStar Medical Group Children's Specialist Nashville Tennessee
United States VA Tennessee Valley Healthcare System - Nashville Campus Nashville Tennessee
United States Vanderbilt University Medical Center - The Vanderbilt Clinic Nashville Tennessee
United States Robert Wood Johnson University Hospital New Brunswick New Jersey
United States Rutgers Cancer Institute of New Jersey New Brunswick New Jersey
United States c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven New Haven Connecticut
United States Smilow Cancer Hospital at Yale-New Haven New Haven Connecticut
United States Yale New-Haven Hospital & Smilow Cancer Center New Haven Connecticut
United States Yale University New Haven Connecticut
United States Memorial Sloan-Kettering Cancer Center New York New York
United States Weill Cornell Medical College - New York-Presbyterian Hospital New York New York
United States Weill Cornell Medical College - New York-Presbyterian Hospital New York New York
United States Children's Hospital of the King's Daughters Norfolk Virginia
United States Kaiser Permanente - Oakland Oakland California
United States Kaiser Permanente - Oakland Medical Center Oakland California
United States Children's Hospital of Orange County Orange California
United States Blood and Marrow Transplant Center Orlando Florida
United States Cancer Institute of Florida Orlando Florida
United States Florida Hospital Cancer Institute Orlando Florida
United States Nemours Children's Hospital Orlando Florida
United States Fox Valley Hematology & Oncology, SC Oshkosh Wisconsin
United States Memorial Cancer Institute at Memorial Hospital West Pembroke Pines Florida
United States Memorial Hospital West Pembroke Pines Florida
United States St. Christopher's Hospital for Children Philadelphia Pennsylvania
United States The Children's Hospital of Philadelphia Philadelphia Pennsylvania
United States Thomas Jefferson University Philadelphia Pennsylvania
United States Thomas Jefferson University (Tju) - Jefferson University Physicians (Jup) Philadelphia Pennsylvania
United States Thomas Jefferson University, Investigative Drug Service Philadelphia Pennsylvania
United States Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Trials Office (Clinical) Philadelphia Pennsylvania
United States Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Trials Office (Regulatory) Philadelphia Pennsylvania
United States Phoenix Children's Hospital Phoenix Arizona
United States Allegheny Health Network, Cancer Institute, West Penn Hospital Pittsburgh Pennsylvania
United States Mayo Clinic Rochester Minnesota
United States University of Rochester Cancer Center Pharmacy Rochester New York
United States University of Rochester Medical Center Rochester New York
United States Kaiser Permanente - Roseville Roseville California
United States Barnes-Jewish Hospital Saint Louis Missouri
United States Siteman Cancer Center - South County Saint Louis Missouri
United States Washington University Infusion Center Pharmacy Saint Louis Missouri
United States Washington University School of Medicine Saint Louis Missouri
United States Washington University School of Medicine, Siteman Cancer Center Saint Louis Missouri
United States Johns Hopkins All Children's Hospital Saint Petersburg Florida
United States Johns Hopkins All Children's Hospital IDS Pharmacy Saint Petersburg Florida
United States Johns Hopkins All Children's Outpatient Care Pediatric Hematology/Oncology Department Saint Petersburg Florida
United States Huntsman Cancer Hospital Salt Lake City Utah
United States Huntsman Cancer Institute-University of Utah Salt Lake City Utah
United States Primary Children's Hospital Salt Lake City Utah
United States UCSD/ Rady Children's Hospital San Diego California
United States Kaiser Permanente - Santa Clara Santa Clara California
United States Lisa Nakatsu, RPh Seattle Washington
United States Seattle Children's Seattle Washington
United States Seattle Children's IDS Pharmacy - Attn. Laura Winter Seattle Washington
United States Swedish Medical Center First Hill, IDS Pharmacy Seattle Washington
United States The West Clinic, P.C. dba West Cancer Center Southaven Mississippi
United States H.Lee Moffitt Cancer Center and Research Institute Tampa Florida
United States Yale Medical Group Trumbull Connecticut
United States Virginia Oncology Associates Virginia Beach Virginia
United States Children's National Medical Center Washington District of Columbia
United States Aurora Health Care, Aurora Cancer Care Wauwatosa Wisconsin
United States Aurora Health Care, Aurora Cancer Care West Allis Wisconsin
United States The University of Kansas Cancer Center and Medical Pavilion Westwood Kansas
United States The University of Kansas Cancer Center and Medical Pavillion Westwood Kansas
United States University of Kansas Cancer Center Westwood Kansas
United States Nemours - A.I. duPont Hospital for Children Wilmington Delaware

Sponsors (1)

Lead Sponsor Collaborator
Pfizer

Country where clinical trial is conducted

United States,